Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1856555918;55919;55920 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
N2AB1692450995;50996;50997 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
N2A1599748214;48215;48216 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
N2B950028723;28724;28725 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
Novex-1962529098;29099;29100 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
Novex-2969229299;29300;29301 chr2:178601304;178601303;178601302chr2:179466031;179466030;179466029
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Fn3-22
  • Domain position: 87
  • Structural Position: 121
  • Q(SASA): 0.1224
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/M rs2053387204 None 0.484 N 0.583 0.132 0.245660935333 gnomAD-3.1.2 6.58E-06 None None None None N None 0 6.56E-05 0 0 0 None 0 0 0 0 0
V/M rs2053387204 None 0.484 N 0.583 0.132 0.245660935333 gnomAD-4.0.0 3.13507E-06 None None None None N None 0 1.71987E-05 None 0 0 None 0 0 3.42001E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.0853 likely_benign 0.0756 benign -1.689 Destabilizing None N 0.253 neutral N 0.421064111 None None N
V/C 0.4846 ambiguous 0.5076 ambiguous -1.179 Destabilizing 0.824 D 0.532 neutral None None None None N
V/D 0.7024 likely_pathogenic 0.5714 pathogenic -1.806 Destabilizing 0.38 N 0.609 neutral None None None None N
V/E 0.527 ambiguous 0.4191 ambiguous -1.703 Destabilizing 0.117 N 0.561 neutral N 0.497812741 None None N
V/F 0.4023 ambiguous 0.3049 benign -1.012 Destabilizing 0.555 D 0.551 neutral None None None None N
V/G 0.273 likely_benign 0.21 benign -2.114 Highly Destabilizing 0.062 N 0.6 neutral N 0.497812741 None None N
V/H 0.7513 likely_pathogenic 0.67 pathogenic -1.753 Destabilizing 0.935 D 0.623 neutral None None None None N
V/I 0.0989 likely_benign 0.0878 benign -0.569 Destabilizing 0.067 N 0.525 neutral None None None None N
V/K 0.598 likely_pathogenic 0.4885 ambiguous -1.551 Destabilizing 0.149 N 0.557 neutral None None None None N
V/L 0.2793 likely_benign 0.2124 benign -0.569 Destabilizing 0.027 N 0.481 neutral N 0.418101164 None None N
V/M 0.1886 likely_benign 0.1535 benign -0.525 Destabilizing 0.484 N 0.583 neutral N 0.516918577 None None N
V/N 0.4695 ambiguous 0.3675 ambiguous -1.526 Destabilizing 0.555 D 0.609 neutral None None None None N
V/P 0.9426 likely_pathogenic 0.9053 pathogenic -0.91 Destabilizing 0.38 N 0.577 neutral None None None None N
V/Q 0.4303 ambiguous 0.3692 ambiguous -1.541 Destabilizing 0.555 D 0.575 neutral None None None None N
V/R 0.5241 ambiguous 0.4204 ambiguous -1.18 Destabilizing 0.38 N 0.616 neutral None None None None N
V/S 0.1759 likely_benign 0.1454 benign -2.095 Highly Destabilizing 0.081 N 0.542 neutral None None None None N
V/T 0.1152 likely_benign 0.1001 benign -1.872 Destabilizing 0.001 N 0.246 neutral None None None None N
V/W 0.9301 likely_pathogenic 0.8898 pathogenic -1.381 Destabilizing 0.935 D 0.661 neutral None None None None N
V/Y 0.7334 likely_pathogenic 0.6574 pathogenic -1.035 Destabilizing 0.555 D 0.559 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.